NDT: Neurodevelopmental Therapy for Spastic Cerebral Palsy

Sponsor
University of Lahore (Other)
Overall Status
Completed
CT.gov ID
NCT05231538
Collaborator
(none)
66
1
2
6.5
10.2

Study Details

Study Description

Brief Summary

This study was conducted to find out the Effects of Neurodevelopment therapy (a rehabilitative program designed by Bobath) on Gross Motor Function and Postural Control in Children with Spastic Cerebral Palsy. To investigate either there was a significant difference between the effects of neurodevelopment therapy and routine physical therapy on gross motor function and postural control in children with Spastic Cerebral Palsy.

Condition or Disease Intervention/Treatment Phase
  • Other: Neurodevelopmental therapy
  • Other: Routine physical therapy
N/A

Detailed Description

A randomized controlled trial was conducted at Department of pediatric rehabilitation, Sher e Rabbani Hospital, Sheikhupura. Sample size was 66 and purposive sampling technique was adopted to collect data. Sample selection was completely based on inclusion and exclusion criteria. A diagnosed Spastic Cerebral Palsy patient aged 2-6 years with no other severe abnormalities such as seizure were recruited. While patients with mental retardation or undergone medical procedures likely to affect motor function such as botulinum toxin injections, orthopedic remedial surgery were excluded. Data was collected at baseline, 4th, 8th and 12th week of the treatment sessions. Gross motor function measure scale (GMFM-88) and posture and postural ability scale (PPAS) were used as data collection tools.

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants are assigned to one of two groups in parallel for the duration of the studyParticipants are assigned to one of two groups in parallel for the duration of the study
Masking:
Single (Outcomes Assessor)
Masking Description:
Assessor was blind to treatment regimen administered to both groups
Primary Purpose:
Treatment
Official Title:
Effects of Neurodevelopment Therapy on Gross Motor Function and Postural Control in Children With Spastic Cerebral Palsy: A Randomized Controlled Trial
Actual Study Start Date :
Jun 17, 2021
Actual Primary Completion Date :
Dec 15, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neurodevelopmental Therapy

The treatment group received neurodevelopment treatment lasting for 3 months (3sessions per week). Additionally, for this study, the NDT programme included passive stretching of the lower limb muscles (e.g. hamstrings, gastrocsoleus), followed by techniques of reducing spasticity and facilitating more normal patterns of movement while working on motor functions. In each session, exercises included patients sustaining themselves on their forearms and hands, sitting, crawling, semi-kneeling, and in standing positions supported by the Physical therapist until tone reduction achieved. Balance and corrective reactions were developed by using a CP ball and tilt board.

Other: Neurodevelopmental therapy
NDT is a hands-on, 'problem solving approach'. It is used in the management and treatment of children who have disorders of function, movement or postural control because of damage in their central nervous system.

Active Comparator: Routine Physical Therapy

The control group underwent the exercises (stretching, passive range of motion, and active range of motion).

Other: Routine physical therapy
stretching, passive range of motion, and active range of motion).

Outcome Measures

Primary Outcome Measures

  1. Gross Motor Function Scale (GMFS) [12 weeks]

    The Gross motor function scale (GMFS) is a standardized observational instrument designed and validated to measure change in gross motor function over time in children with cerebral palsy. The scoring system of the GMFM is a four-point scale divided into five categories lying and rolling; sitting; crawling and kneeling; standing; walking, running

  2. The Posture and Postural Ability Scale (PPAS) [12 weeks]

    The Posture and Postural Ability Scale (PPAS) is a 7-point ordinal scale for the assessment of postural ability in standing, sitting, supine and prone. There are six items for assessment of quality of posture in the frontal plane and another six items in the sagittal plane

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • • A diagnosed Spastic Cerebral Palsy (patient's diagnosis of CP confirmed by an expert pediatrician neurologist)

  • Spastic CP

  • No other severe abnormalities such as seizure

  • Aged 2-6 years

  • Both Genders

Exclusion Criteria:
  • Medical procedures likely to affect motor function such as botulinum toxin injections

  • Orthopedic remedial surgery

  • Mental retardation, or a learning disability.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Lahore Teaching Hospital Lahore Punjab Pakistan 54000

Sponsors and Collaborators

  • University of Lahore

Investigators

  • Principal Investigator: Abdullah Khalid khan, MSNPT, The university of lahore

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abdullah Khalid Khan, Principal Investigator, University of Lahore
ClinicalTrials.gov Identifier:
NCT05231538
Other Study ID Numbers:
  • IRB-UOL-FAHS/882/2021
First Posted:
Feb 9, 2022
Last Update Posted:
Feb 9, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Abdullah Khalid Khan, Principal Investigator, University of Lahore
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2022